Accordingly, we set out to assess the demographics, clinical characteristics, and outcomes of a large cohort of patients (n ≈ 30 000) who have had their Lp(a) measured over the last 20 years to further understand the association between Lp(a) levels and cardiovascular disease. This evidence concerns the gene LPA and cardiovascular disorder.